197 related articles for article (PubMed ID: 24363128)
21. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome.
Hamasaki Y; Yoshikawa N; Hattori S; Sasaki S; Iijima K; Nakanishi K; Matsuyama T; Ishikura K; Yata N; Kaneko T; Honda M;
Pediatr Nephrol; 2009 Nov; 24(11):2177-85. PubMed ID: 19714370
[TBL] [Abstract][Full Text] [Related]
22. Retrospective single-arm cohort study of steroid-dependent minimal change nephrotic syndrome treated with very low-dose rituximab.
Fujimoto K; Kagaya Y; Kumano S; Fujii A; Tsuruyama Y; Matsuura T; Yamazaki K; Nomura K; Okada K; Okino K; Adachi H; Furuichi K; Yokoyama H
Clin Nephrol; 2021 Jan; 95(1):29-36. PubMed ID: 33074094
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine experience in nephrotic syndrome.
Phadke K; Ballal S; Maiya V
Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
[TBL] [Abstract][Full Text] [Related]
25. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.
Iijima K; Sako M; Oba MS; Ito S; Hataya H; Tanaka R; Ohwada Y; Kamei K; Ishikura K; Yata N; Nozu K; Honda M; Nakamura H; Nagata M; Ohashi Y; Nakanishi K; Yoshikawa N;
Clin J Am Soc Nephrol; 2014 Feb; 9(2):271-8. PubMed ID: 24262503
[TBL] [Abstract][Full Text] [Related]
30. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin-A in the treatment of nephrotic syndrome: the importance of monitoring C0 (trough) and C2 (two hours after its administration) blood levels.
Goumenos DS; Kalliakmani P; Tsakas S; Savidaki I; Vlachojannis JG
Med Chem; 2006 Jul; 2(4):391-3. PubMed ID: 16848751
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
Ladapo TA; Esezobor CI; Lesi FE
Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporin A absorption profiles in children with nephrotic syndrome.
Nozu K; Iijima K; Sakaeda T; Okumura K; Nakanishi K; Yoshikawa N; Honda M; Ikeda M; Matsuo M
Pediatr Nephrol; 2005 Jul; 20(7):910-3. PubMed ID: 15856324
[TBL] [Abstract][Full Text] [Related]
34. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD; MacLeod R; Rigby E; Clark AG
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[TBL] [Abstract][Full Text] [Related]
35. Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
Fujinaga S; Ohtomo Y; Someya T; Shimizu T; Yamashiro Y; Kaneko K
Clin Nephrol; 2008 Feb; 69(2):84-9. PubMed ID: 18218301
[TBL] [Abstract][Full Text] [Related]
36. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome.
Yuan H; Liu N; Sun GD; Jia Y; Luo P; Miao LN
Pharmacology; 2013; 91(5-6):259-66. PubMed ID: 23652322
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome.
Naito M; Takei T; Eguchi A; Uchida K; Tsuchiya K; Nitta K
Intern Med; 2008; 47(18):1567-72. PubMed ID: 18797114
[TBL] [Abstract][Full Text] [Related]
38. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
Hino S; Takemura T; Okada M; Murakami K; Yagi K; Fukushima K; Yoshioka K
Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
